Join us at the European Antibody Congress in Basal October 15th-17th. At BioIVT, we specialize in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. Our PHASEZERO® Research Services team works collaboratively with clients to provide target and biomarker validation, phenotypic assays to characterize novel therapeutics, clinical assay development and in vitro hepatic modeling solutions.
Make sure to join our round table: The Development of Multiplex IHC Targeting Biomarker Identification by Madhumita Das, PhD. During this presentation, Dr Das will discuss:
- The ability of multiplex immunohistochemistry to allow the simultaneous detection of up to seven therapeutic/cellular targets of interest in a single tissue section
- How characterizing tumor, microenvironment and profiling infiltrating immune cells is important for predictive biomarker discovery for disease prognosis and evaluation of treatment response in cancer patients
- A case study detailing assay development and validation of a fit-for-purpose multiplex IHC assay in NSCLC
By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.